Evidence map›Paper›PMID 37726541›Full record

ArticleNature genetics2023

Author Correction: Multiparameter prediction of myeloid neoplasia risk.

Muxin Gu, Sruthi Cheloor Kovilakam, William G Dunn, Ludovica Marando, Clea Barcena, Irina Mohorianu, Alexandra Smith, Siddhartha P Kar, Margarete A Fabre, Moritz Gerstung and 4 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Muxin GuWellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Sruthi Cheloor KovilakamWellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
William G DunnWellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Ludovica MarandoWellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Clea BarcenaWellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-7452-2536
Irina MohorianuWellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Alexandra SmithEpidemiology and Cancer Statistics Group, University of York, York, UK.
Siddhartha P KarMRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.ORCID http://orcid.org/0000-0002-2314-1426
Margarete A FabreWellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Moritz GerstungDivision of Artificial Intelligence in Oncology, DKFZ, Heidelberg, Germany.
Catherine A CargoHaematological Malignancy Diagnostic Service, St James's Hospital, Leeds, UK.
Luca MalcovatiDepartment of Molecular Medicine, University of Pavia, Pavia, Italy.ORCID http://orcid.org/0000-0002-1460-1611
Pedro M QuirosWellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. pmquiros@ispasturias.es.ORCID http://orcid.org/0000-0002-7793-6291
George S VassiliouWellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. gsv20@cam.ac.uk.ORCID http://orcid.org/0000-0003-4337-8022

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37726541
PMCPMC10562208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.